Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	54.3	89.14	60.08	127.68	59.25
Short-Term Investments	334.65	231.43	215.77	205.61	235.61
Cash & Short-Term Investments	388.95	320.57	275.85	333.29	294.86
Cash Growth	21.33%	16.21%	-17.23%	13.04%	70.64%
Receivables	26.08	18.51	14.87	6.22	1.03
Inventory	25.75	18.74	8.62	2.92	0.11
Prepaid Expenses	26.13	-	-	-	-
Other Current Assets	-	16.38	8.93	11.81	12.4
Total Current Assets	466.92	374.2	308.27	354.24	308.39
Property, Plant & Equipment	4.15	4.11	2.12	3.38	4.34
Other Intangible Assets	5.32	6.17	7.03	7.88	4.66
Long-Term Deferred Charges	-	6.21	12.59	-	-
Other Long-Term Assets	3.81	1.58	2.73	16.98	12.14
Total Assets	480.2	392.27	332.75	382.48	329.52
Accounts Payable	13.95	12.33	4.89	4.8	5.74
Accrued Expenses	83.86	58.31	42.85	30.48	29.26
Current Portion of Long-Term Debt	7.3	1.54	-	-	-
Current Portion of Leases	0.65	-	0.77	0.68	0.61
Current Unearned Revenue	0.19	1.29	1.29	1.43	7
Other Current Liabilities	-	42.05	5.41	2.42	0.83
Total Current Liabilities	105.94	115.52	55.2	39.81	43.43
Long-Term Debt	100.89	108.27	106.14	75.81	-
Long-Term Leases	3.34	3.94	0.49	1.26	1.95
Other Long-Term Liabilities	-	-	1.15	1.34	-
Total Liabilities	210.17	227.72	162.99	118.22	45.37
Common Stock	0.07	0.06	0.06	0.06	0.05
Additional Paid-In Capital	1,492	1,177	1,064	974.36	813.04
Retained Earnings	-1,352	-1,155	-894.74	-710.06	-528.94
Comprehensive Income & Other	-0.8	-0.04	0.13	-0.09	-0
Total Common Equity	139.07	21.73	169.76	264.26	284.15
Shareholders' Equity	270.03	164.55	169.76	264.26	284.15
Total Liabilities & Equity	480.2	392.27	332.75	382.48	329.52
Total Debt	112.17	113.75	107.4	77.75	2.55
Net Cash (Debt)	276.78	206.82	168.44	255.53	292.3
Net Cash Growth	33.83%	22.78%	-34.08%	-12.58%	72.24%
Net Cash Per Share	4.26	3.39	2.92	4.90	5.89
Filing Date Shares Outstanding	67.21	63.22	60.14	56.75	50.33
Total Common Shares Outstanding	67.21	62.39	59.43	56.61	50.28
Working Capital	360.97	258.68	253.07	314.43	264.96
Book Value Per Share	2.07	0.35	2.86	4.67	5.65
Tangible Book Value	133.75	15.56	162.73	256.38	279.49
Tangible Book Value Per Share	1.99	0.25	2.74	4.53	5.56
Machinery	-	2.69	2.7	2.65	2.37
Leasehold Improvements	-	2.71	2.71	2.71	2.71

Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q